Researchers investigated immunologic and clinical findings indicative of SARS-CoV-2 exposure among individuals with postviral syndrome.
Bipartisan House bill seeks to boost pediatric drug development via new FDA penalties for noncompliance
A bipartisan duo of lawmakers is seeking to boost pediatric drug development with new legislation that would prioritize adding pediatric patients to trials for new